The Official Newsletter of ASAAP Project | No. 03 | June 2024

The Official Newsletter of ASAAP Project | No. 03 | June 2024

During the peak of our recruitment efforts and the implementation of the Main study, an annual meeting was held in Cotonou, Benin from 06-07 June 2023. The purpose of the meeting was to reinforce our collaboration through the exchange of profound ideas, address the challenges encountered, and develop practical and realistic solutions to ensure the timely completion of the project. The meeting was attended by team members of the various WPs, Leads and Co-leads, Study Coordinators from all partner institutions. In attendance was also Pharmalys, the Contract Research Organization (CRO) for the ASAAP trial. Over the course of these two days, the meeting featured presentations and interactive sessions aimed at addressing various challenges related to the study. These discussions encompassed the streamlining of data collection and handling of queries, as well as the harmonization of safety reports. Furthermore, the gathering provided a valuable opportunity to engage with investigators and study coordinators, enabling discussions on recruitment rates and strategies to enhance participant enrollment across the study sites. ASAAP Student fellows have also the opportunity to present the progress made in their MSc/PhD project.

ASAAP Newsletter - No. 2

The Official Newsletter of ASAAP Project | No. 02 | July 2022

The ASAAP pilot study assessed the safety and tolerability of Artemether- Lumefantrine+Atovaquone-Proguanil (AL+AP) and AL + placebo for the treatment of uncomplicated Plasmodium falciparum malaria in adults and adolescents, prior to rolling out a multi-centre evaluation of the same two treatments in young children. The last of sixty participants in the Pilot study was recruited on January 15, 2021, at the Centre de Recherches Médicales de Lambaréné (CERMEL) in Lambaréné in Gabon.

 

Congratulations to the Gabon team for successfully completing the Pilot study!

The Official Newsletter of ASAAP Project | No. 01 | February 2021

On October 26, 2020, ASAAP recruited an adult patient diagnosed with uncomplicated malaria at the Centre de Recherches Médicales de Lambaréné (CERMEL) in Lambaréné in Gabon as its first study participant. This recruitment marked the initiation of the pilot study, which results would inform the final stages of preparations for implementing the multi-country trial.